Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1976-1-16
pubmed:abstractText
Activation of the classical complement (C) system involves conversion of C1 to its active state with subsequent cleavage of C4 and -d C2 so as to form the classical C3 convertase, C42 (a bar indicates the activated form of a protein), which sequentially cleaves C3 and C5 to initiate the cytolytic event associated with the complete reaction. An alternative, pr properdin-dependent, pathway to complement activation generates a C3 convertase, C3B, that is formed by cleavage of B with D in the presence of a C3b, the major cleavage fragment of C3. C3b is capable of binding activated properidin (P) with resultant stabilization of C3B, which otherwise rapidly decays by loss of B activity. Initial cleavage of C3, a prerequisite for formation of C3B, is demonstrated to occur through the interaction of native C3 and B in the presence of either D or P alone, or together. The effect of P on the interaction of D, B, and C3 is attributed to stabilization of C3B as has been shown for C3B. Larger amounts of P and B with C3 in the absence of D form a C3 convertase that is designated (P)C3B to indicate that demonstrable cleavage of B does not occur although the active site is available. The generation of this initial convertase, as assessed by C3 inactivation, is dose-related to P and B inputs. The presence of both P and D greatly augments initial cleavage of C3 with D fully uncovering the active site of B and P stabilizing that site.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-13186838, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-13801696, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-13929797, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-14280442, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-14316946, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4105810, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4111773, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4115613, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4161754, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4168662, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4169693, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4202731, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4211020, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4719679, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4734384, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4734403, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4734404, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4808709, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-4855753, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-5813010, http://linkedlifedata.com/resource/pubmed/commentcorrection/1059108-6019133
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3220-4
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1975
pubmed:articleTitle
Properdin: initiation of alternative complement pathway.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.